Omalizumab for the treatment of severe persistent allergic asthma in children aged 6–11 years

• S Walker,
• J Burch,
• C McKenna,
• K Wright,
• S Griffin,
• N Woolacott

Affiliations

S Walker

J Burch

C McKenna

K Wright

S Griffin

N Woolacott